HIGH-THROUGHPUT SCREEN OF ADVANCED PROSTATE CANCER ORGANOIDS AND PDX PRECLINICAL TRIALS TO IDENTIFY SINGLE AND COMBINATION THERAPIES CORRELATED WITH
$765,046FY2018Department of the ArmyDOD
The Geneva Foundation
Investigators
View source on USAspending →HIGH-THROUGHPUT SCREEN OF ADVANCED PROSTATE CANCER ORGANOIDS AND PDX PRECLINICAL TRIALS TO IDENTIFY SINGLE AND COMBINATION THERAPIES CORRELATED WITH · GrantIndex